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The S. cerevisiae genome encodes two M16A enzymes: Axl1p and Ste23p.  Of the two, Ste23p 
shares significantly higher sequence identity with M16A enzymes from other species, including 
mammalian insulin-degrading enzymes (IDEs).  In this study, recombinant Ste23p and R. 
norvegicus IDE (RnIDE) were isolated from E. coli, and their enzymatic properties compared.  
Ste23p was found to cleave established RnIDE substrates including the amyloid-β  peptide (Aβ  1-40) 
and insulin B chain.  A novel internally quenched fluorogenic substrate (Abz-SEKKDNYIIKGV-
nitroY-OH) based on the polypeptide sequence of the yeast P2 a-factor mating propheromone was 
determined to be a suitable substrate for both Ste23p and RnIDE, and was used to conduct 
comparative enzymological studies.  Both enzymes were most active at 37 °C, in alkaline buffers, 
and in high salt environments.  In addition, the proteolytic activities of both enzymes towards the 
fluorogenic substrate were inhibited by metal chelators, thiol modifiers, inhibitors of cysteine 
protease activity, and insulin.  Characteristics of STE23 expression were also evaluated.  Our 
analysis indicates that the 5´ terminus of the STE23 gene has been mischaracterized, with the 
physiologically relevant initiator corresponding to residue M53 of the publicly annotated protein 
sequence.  Finally, we demonstrate that unlike haploid-specific Axl1p, Ste23p is expressed in both 
haploid and diploid cell types.  Our study presents the first comprehensive biochemical analysis of a 
yeast M16A enzyme, and provides evidence that S. cerevisiae Ste23p has enzymatic properties that 
are highly consistent with mammalian IDEs and other M16A enzymes. 
 
INTRODUCTION 
The M16A subfamily comprises a group of 
large (~100 kDa), zinc-dependent metallo-
endopeptidases, which are found within all 
prokaryotic and eukaryotic organisms that have 
been thoroughly examined (Rawlings, 2008).  
M16A enzymes are characterized by the presence 
of an essential HxxEH motif generally located 
within 200 residues of the amino terminus.  These 
residues are responsible for zinc coordination and 
catalysis (Becker and Roth, 1992). 
Structural characterization of M16A subfamily 
enzymes has been reported (Im, et al., 2007; 
Maskos, 2005; Shen, et al., 2006).  M16A 
enzymes have quaternary structure that is similar 
to a clamshell in appearance, with N- and C-
terminal bowl-shaped domains of approximately 
50 kDa connected by a short linker region of 20-
30 residues.  Both the N- and C-terminal domains, 
as well as individual residues from highly 
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conserved sequences within each domain, are 
required for the catalytic function of M16A 
enzymes (Alper, et al., 2006; Becker and Roth, 
1993; Ding, et al., 1992; Kim, et al., 2005; Li, et 
al., 2006; Perlman, et al., 1993).  Recent studies of 
the human insulin-degrading enzyme (HsIDE) and 
bacterial pitrilysin (EcPtr) have demonstrated that 
M16A enzymes can adopt either an ‘open’ 
conformation, which is hypothesized to permit 
substrate access to a central catalytic 
compartment, or a ‘closed’ conformation, which is 
presumed to be necessary for proteolysis, yet 
likely prohibits entrance and exit of substrates 
from the catalytic site (Maskos, 2005; Shen, et al., 
2006).  Transitions between the ‘open’ and 
‘closed’ conformations of M16A enzymes are 
hypothesized to represent a rate-limiting step 
within these enzymes’ catalytic cycles.  Consistent 
with this hypothesis, mutations that disrupt 
interactions between the N- and C-terminal 
domains of HsIDE increase catalytic activity by as 
much as 40-fold (presumably by facilitating the 
transition between the open and closed 
conformations of the enzyme) (Shen, et al., 2006).  
Allosteric regulation of HsIDE and R. norvegicus 
IDE (RnIDE) by ATP has been reported, although 
the underlying reason for such regulation is not 
understood at present (Camberos, 2001; Song, et 
al., 2004).  Eukaryotic M16A enzymes also 
demonstrate sensitivity to N-ethylmaleimide 
(NEM) and other thiol modifiers, though the 
mechanistic importance of cysteine residues 
within these enzymes remains poorly elucidated 
(Becker and Roth, 1995; Kim, et al., 2005; Neant-
Fery, et al., 2008). 
M16A enzymes have broad yet selective 
substrate specificity.  Established substrates of 
M16A enzymes include insulin, amyloid beta (Aβ) 
peptides, glucagon, amylin, plant systemin, and 
yeast P2 pro-a-factor, among others (Adames, et 
al., 1995; Alper, et al., 2006; Bennett, et al., 2000; 
Huet, et al., 2008; Kim, et al., 2005; Kirschner and 
Goldberg, 1983; Qiu, et al., 1998).  Structural 
studies of HsIDE in complex with multiple peptide 
substrates have revealed several features that play 
a role in substrate recognition by this and 
presumably other M16A enzymes (Maskos, 2005; 
Shen, et al., 2006).  To be recognized by HsIDE, 
potential substrates must be capable of anchoring 
within the enzyme’s catalytic binding pocket and 
forming favorable interactions with enzymatic β-
strands proximal to the site of peptide hydrolysis.  
Potential substrates must also be small enough 
(~50 amino acids in length) to permit 
encapsulation within the central chamber of the 
closed enzyme.  Peptides with significant positive 
charge at their C-terminus are generally poor 
substrates due to unfavorable electrostatic 
interactions with the positively charged face of the 
central chamber contributed by the C-terminal 
domain of the enzyme (Shen, et al., 2006).  No 
absolute primary sequence determinant has been 
reported among substrates of the M16A subfamily.  
However, studies of RnIDE using synthetic 
fluorogenic peptides have shown that the enzyme 
preferentially cleaves on the amino side of 
hydrophobic and basic residues (Song, et al., 
2005), and studies of S. lycopersicum IDE (SlIDE) 
using various alternative peptide substrates have 
further suggested a limited preference for proline 
one or two residues N-terminal to the site of 
proteolytic cleavage (Huet, et al., 2008), which 
may reflect an overall preference for substrates 
that adopt a β-turn structure (Kurochkin, 1998). 
Medical interest in the M16A subfamily has 
been motivated in part by the proposal that HsIDE 
serves a protective function in forestalling the 
onset of Alzheimer’s disease (AD) (Hardy and 
Selkoe, 2002; Selkoe, 2001).  Human population 
studies have indicated that variations in and 
around the chromosomal locus encoding HsIDE 
are risk factors for AD and Type II diabetes 
mellitus (DM2) (Ertekin-Taner, et al., 2000; 
Groves, et al., 2003; Kim, et al., 2007; Myers, et 
al., 2000).  Consistent with these observations, 
IDE deficiency or loss of function in rodent 
models has been correlated with increased levels 
of Aβ and insulin, as well as increased incidence 
of AD and DM2 (Farris, et al., 2003; Leissring, et 
al., 2003; Miller, et al., 2003).  Levels of soluble 
and insoluble Aβ and premature death rates are 
also significantly reduced in transgenic rodent 
models in which both IDE and the amyloid 
precursor protein, APP, have been overexpressed 
(Leissring, et al., 2003). 
Ste23p and Axl1p are the M16A enzymes 
native to S. cerevisiae.  Genetic studies support 
involvement of Ste23p and Axl1p in exacting an 
N-terminal endoproteolytic cleavage of the P2 
precursor of the a-factor mating pheromone that is 
produced by MATa haploid cells.  MATa yeast that 
lack functional copies of both Ste23p and Axl1p 
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cannot signal mating competency to cells of the 
complementary mating type and thus exhibit a 
‘sterile’ mating phenotype (Adames, et al., 1995).  
Axl1p expression is restricted to haploid yeast 
(Fujita, et al., 1994), where, in addition to its role 
in a-factor processing, the enzyme has several 
other known functions.  These include 
maintenance of a haploid-specific axial budding 
pattern (Adames, et al., 1995; Fujita, et al., 1994), 
repression of haploid-specific invasive growth 
(Cullen and Sprague, 2002; Palecek, et al., 2000), 
and promotion of efficient haploid cell fusion 
during mating (Elia and Marsh, 1996).  As 
documented in this study, and by contrast to the 
haploid-specific expression of Axl1p, Ste23p is 
expressed in both haploid and diploid yeast.  
Despite its broad expression profile, the only 
known function of Ste23p is in a-factor 
processing, a MATa-specific event.  Its role in 
MATα and diploid cells, which may also be 
conserved in MATa cells, remains enigmatic.  
Ste23p and Axl1p are not functionally equivalent 
in terms of their ability to promote mature a-factor 
production.  Ste23p is responsible for at most 5% 
of all a-factor production, yet it is expressed at 
steady state levels that are at least ten times higher 
than that observed for Axl1p (Adames, et al., 
1995; Alper, et al., 2006).  These observations 
suggest an alternative biological function of 
Ste23p that has yet to be identified. 
We now report a comparative biochemical 
analysis of yeast Ste23p and RnIDE.  We 
demonstrate that Ste23p exhibits conserved 
specificity towards established RnIDE substrates 
Aβ 1-40 and insulin B chain, and has enzymatic 
characteristics that are similar to those of RnIDE 
and other eukaryotic M16A enzymes.  In addition, 
we provide genetic and biochemical evidence that 
the 5´ terminus of the STE23 ORF has been 
mischaracterized.  This study presents the first 
detailed biochemical analysis of a fungal M16A 
enzyme, and supports the suitability of Ste23p as a 
model for continuing studies of the M16A 
subfamily within S. cerevisiae. 
 
MATERIALS AND METHODS 
Sequence comparisons- Polypeptide sequences 
of M16A enzymes from several commonly studied 
organisms were evaluated using the multiple 
global sequence alignment function of Clustal W 
2.0.10 with default parameters (Larkin, et al., 
2007; Wilbur and Lipman, 1983).  Polypeptide 
sequences for HsIDE, RnIDE, Drosophila 
melanogaster IDE (DmIDE), SlIDE and EcPtr are 
equivalent to the UniProtKB/Swiss-Prot protein 
sequence entries P14735, P35559, P22817, 
Q93YG9, and P05458, respectively (Leinonen, et 
al., 2004).  The polypeptide sequence for 
Caenorhabditis elegans IDE (CeIDE) corresponds 
to WormBase protein entry WP:CE37861 (Bieri, 
et al., 2007; Stein, et al., 2001).  Polypeptide 
sequences for Ste23p and Axl1p correspond to the 
Ste23p and Axl1p protein sequences annotated 
within the Saccharomyces Genome Database 
(Cherry, et al., 1998).  The polypeptide sequence 
for Ustilago maydis Ste23p (UmSte23p) was 
inferred from U. maydis genomic locus 
UM03257.1 (Harvard, 2008), and the polypeptide 
sequence for Schizosaccharomyces pombe 
(SpSte23p) was inferred from S. pombe genomic 
locus NP_593966 (Wood, et al., 2002).  Graphical 
representation of the Ste23p and RnIDE alignment 
was created using BOXSHADE 3.21. 
Yeast strains and plasmids- The yeast strains 
and plasmids used in this study are listed in Tables 
1 and 2, respectively.  Yeast strains were grown at 
30 °C in solid or liquid rich media (YEPD) or 
synthetic complete (SC) dropout medium.  
Plasmids p80, pRS316, pWS371, pWS375, 
pWS482, pWS512 and pWS514 have been 
previously described (Adames, et al., 1995; Kim, 
et al., 2005; Sikorski and Hieter, 1989).  Plasmids 
having 5´ sequence deletions (pWS759-763) were 
created by direct subcloning of PCR products 
derived from pWS375, which were designed to 
lack the appropriate DNA region and contain KpnI 
and HindIII restriction sites that were subsequently 
used to insert the PCR product into corresponding 
sites of pWS482; the KpnI site is within the 
pWS482 polylinker, and HindIII is internal to the 
STE23 ORF.  A plasmid lacking 5´ sequence and 
the first predicted 156 nucleotides of STE23 
(pWS765) was created in a similar manner.  
pWS908 and pWS909 were obtained 
commercially (Norclone Biotech Laboratories, 
London, Ontario).  Yeast transformations were 
carried out according to established methods 
(Elble, 1992). 
Bacterial strains and plasmids- Bacterial 
strains and plasmids used within this study are 
included in Tables 1 and 2.  DH5α E. coli 
(Invitrogen Inc., San Diego, CA) was used for 
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amplification of plasmid DNA, and BL21(DE3) E. 
coli (Novagen Inc., Darmstadt, Germany) was 
used for protein expression.  pET30-b(+) 
(Novagen Inc.) was used as the vector for 
recombinant expression of Ste23p and RnIDE.  
Bacterial cells were prepared for chemical 
transformation according to established methods 
(Hanahan, 1983). 
Vectors for recombinant expression of STE23 
and RnIDE were created within pET30-b(+) such 
that each encoded an N-terminal polyhistidine tag 
immediately behind a start codon.  pWS769 
(6xHis-Ste23pM53-E1027) was created by subcloning 
a PCR fragment encoding the region of the STE23 
gene corresponding with residues M53-E1027 of 
the annotated Ste23p polypeptide sequence.  This 
sequence was amplified from pWS375 such that 
an NdeI site, an ATG codon, and sequence 
encoding a 6xHis tag were created at the 5´ end of 
the fragment and a NotI site was created at the 3´ 
end.  This strategy permitted direct subcloning into 
corresponding sites within the pET-30b(+) vector.  
Construction of pWS804 (6xHis-RnIDEM42-L1019) 
was achieved in an analogous fashion and has 
been described (Alper and Schmidt, 2009).  DNA 
sequencing analysis revealed two mutations 
encoding single-site amino acid substitutions 
Y248C and E768A within the plasmid encoding 
RnIDE.  The corresponding native residues are not 
conserved between RnIDE and Ste23p, and are 
positioned distal to the catalytic site as inferred 
from analogous residues within HsIDE, the most 
closely related RnIDE homolog for which 
structural data is available. 
Enzyme purification- 6xHis-Ste23pM53-E1027 
and 6xHis-IDEM42-L1019 were expressed within 
BL21 (DE3) E. coli and purified by immobilized 
nickel affinity chromatography according to our 
established methods (Alper and Schmidt, 2009).  
In brief, a clarified cell lysate containing the 
protein of interest was applied onto a HisTrap™ 
Fast Flow 5 mL column that was attached to an 
AKTAprime™ FPLC system (GE Healthcare Inc., 
Piscathaway, NJ).  Block elution with 0.5 M 
imidazole was used to recover the bound protein 
after washes to remove unbound material.  The 
imidazole concentration in the eluted sample was 
reduced by first concentrating the sample to 
approximately 1 mL using an Amicon Ultra™-15 
mL 100 kDa MW-cutoff centrifugal filter device 
(Millipore Inc., Bedford MA), and then diluting 
the sample approximately 10-fold with Lysis 
Buffer (50 mM HEPES, 140 mM NaCl, pH 7.4).  
The dilution and concentration steps were repeated 
once more prior to diluting the final sample to 1 
mg/mL in Storage Buffer (Lysis Buffer containing 
20% glycerol (v/v)). Molarities of the purified 
enzymes were determined prior to dilution from 
UV absorbance measurements and A280 extinction 
coefficients according to established methods (Gill 
and von Hippel, 1989).  These values were 
consistent with those determined by Bradford 
assay.  Sample aliquots were stored at -80 °C and 
thawed as needed. 
Peptides and reagents- Recombinant human 
Aβ 1-40 (rPeptide Inc., Athens, GA), human 
insulin, and insulin B chain (Sigma-Aldrich Inc., 
St. Louis, MO) and the quenched fluorogenic Abz-
SEKKDNYIIKGV-nitroY-OH peptide (AnaSpec 
Inc., San Jose, CA) were all reconstituted from dry 
powders.  Detailed preparation of Aβ 1-40 and 
insulin solutions has been reported elsewhere 
(Alper and Schmidt, 2009).  In brief, Aβ 1-40 was 
treated with hexafluoroisopropanol (HFIP) to 
ensure the initial monomeric state of the peptide 
(Dahlgren, et al., 2002), and dissolved within 
dimethylsulfoxide (DMSO) to a final 
concentration of 4 mg/mL.  Insulin was 
resuspended in DMSO to 4 mg/mL and sonicated 
using a bath sonicator (Branson Inc., Danbury, 
CT) for approximately 5 min to fully dissolve the 
peptide.  Insulin B chain was resuspended in 
DMSO to a final concentration of 4 mg/mL, but 
did not require sonication for complete solubility.  
The Abz-SEKKDNYIIKGV-nitroY-OH peptide 
was resuspended directly within DMSO to a final 
concentration of 10 mM.  After reconstitution, all 
peptide-containing solutions were stored at -80 °C.  
Ethylenediaminetetraacetic acid (EDTA), N-
ethylmaleimide (NEM), free cysteine, β-
mercaptoethanol (β-ME), dithiothreitol (DTT), 
adenosine-5´-triphosphate (ATP), and guanosine 
triphosphate (GTP) were prepared as 10 mM 
stocks in deionized water.  N,N,N´-tetrakis(2-
pyridylmethyl)ethylenediamine (TPEN), 1,10-
phenanthroline (1,10-P.), 4,7-phenanthroline (4,7-
P.), and phenylmethylsulphonyl fluoride (PMSF) 
were prepared as 50 mM stocks in DMSO. 
Capillary electrophoresis- Aβ 1-40 and insulin 
B chain proteolysis were analyzed by capillary 
electrophoresis (CE) as previously described 
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(Alper and Schmidt, 2009).  In brief, proteolytic 
reactions (40 µL) were conducted in CE 
Proteolysis Buffer (10 mM potassium phosphate, 
pH 7.6) at 30 °C (Ste23p) or at 37 °C (RnIDE) 
using 20 nM enzyme and an initial substrate 
concentration of 0.1 mg/mL (Aβ 1-40 and insulin 
B chain).  Enzyme and substrate mixes were 
independently prepared as 2x reaction pre-
mixtures by dilution within CE Proteolysis Buffer 
that was warmed at 30 °C or 37 °C for 10 min, 
prior to mixing the pre-mixtures within a pre-
warmed PCR tube to initiate the proteolytic 
reaction.  Proteolysis was terminated after 
appropriate intervals by heating the reaction 
mixture to 80 °C for 3 min.  Samples were then 
stored at -80 °C prior to analysis.  
Fluorescence assay- An internally quenched 
fluorogenic dodecapeptide substrate centered on 
the M16A proteolytic cleavage site within the 
yeast P2 a-factor mating propheromone (Abz-
SEKKDNYIIKGV-nitroY-OH) was used to 
monitor the activity of 6xHis-Ste23pM53-E1027 and 
6xHis-IDEM42-L1019 under steady-state reaction 
conditions.  This substrate contains a fluorescent 
aminobenzoic acid moiety (Abz) that is linked 
through the peptide backbone to a nitrotyrosine 
(nitroY) fluorescence quencher.  Proteolytic 
cleavage results in enhanced sample fluorescence, 
which can be quantified using a fluorimeter. 
Effects of various environmental conditions 
upon the enzymatic activities of Ste23p and 
RnIDE were evaluated by manipulating a 
component condition of the fluorescence assay 
reaction mixture while holding all others constant.  
The standard conditions for assays containing 
Ste23p (20 nM) were 100 mM potassium 
phosphate, pH 8.1 and 30 °C; the standard 
conditions for RnIDE (50 nM) were 100 mM 
potassium phosphate, pH 9.2, and 37 °C.  
Potassium phosphate buffers were prepared 
according to published methods (Gomori, 1956).  
In general, the use of phosphate buffers was found 
to permit maximal enzymatic activity relative to 
alternative buffering systems (Alper, Rowse, and 
Schmidt, unpublished observations).  The initial 
Abz-SEKKDNYIIKGV-nitroY-OH peptide 
concentration was 17 µM.  Kinetic parameters 
were determined using the standard conditions 
described above and initial substrate 
concentrations ranging from 3 – 172 µM. 
Typical assembly of the reaction mixture 
involved 1:1 mixing of appropriately diluted 
substrate and enzyme solutions within an 
individual well of a pre-warmed, black, flat-
bottomed fluorescence microtiter plate.  The 
fluorogenic substrate was prepared as a 2x 
reaction pre-mixture by dilution with appropriate 
buffer in a PCR tube, and pre-equilibrated for 10 
min at the desired temperature.  Ste23p and RnIDE 
were similarly prepared.  Where noted, pre-
mixtures contained competing substrate (0.16 
mg/mL insulin) or added compounds (2 mM), the 
latter preincubated with the enzyme for 10 min.  
Proteolysis was initiated by combining the 2x pre-
mixtures.  The total reaction volume of a typical 
assay was 100 µL, except in the instance of 
experiments involving Km determination, where 
the total volume was 30 µL in an effort to permit 
conservation of substrate.  Larger volume samples 
were combined in a 96-well microtiter plate; 
smaller volumes were combined in a 384-well 
plate.  Sample fluorescence was analyzed at 420 
nm over multiple time points over a 60 min time 
course using a Bio-Tek® Synergy™ HT 
fluorimeter equipped with a 320/420 nm 
excitation/emission filter set (Bio-Tek® 
Instruments, Inc., Winooski, VT). 
As controls for the fluorescence assay, 
background and maximum fluorescence signals 
were determined as reference points for all 
conditions evaluated.  This analysis was 
performed to identify reaction conditions that 
modulated fluorescence of the reporter.  The 
background fluorescence signal was determined in 
the absence of added enzyme, while retaining all 
other components of the experimental reaction 
mixture described above.  The maximum 
fluorescence signal was determined in the 
presence of trypsin (5 µg/mL), which cleaves the 
Abz-SEKKDNYIIKGV-nitroY-OH substrate, 
after the proteolytic reaction was allowed to 
proceed to completion.  In instances where 
fluorescence was affected (e.g. altered pH, certain 
added compounds), the absolute difference 
between the negative and positive controls was 
used as a normalization factor to calculate the 
relative fluorescence output of the sample.  Rate 
values observed in the presence of added 
compounds are reported relative to those for the 
untreated enzymes. 
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Rate Calculations- Data obtained by 
fluorescence assay was analyzed using Microsoft 
Excel™ and GraphPad Prism™ 4.0 Software.  
Reaction velocity was determined from 10 to 30 
min after the initiation of each experiment, or up 
to such time as a maximum of 10% substrate 
proteolysis was achieved, allowing for an initial 
lag period upon mixing of enzyme and substrate 
pre-mixtures.  Reported values represent the 
average of least 3 experimental replicates each 
derived from 10 experimental data points 
satisfying the conditions described above.  
Maximal reaction velocity and initial reaction 
velocity were taken to be equivalent for purposes 
of this analysis.  Kinetic parameters for Ste23p 
and RnIDE were determined using nonlinear 
regression curve-fitting software within Prism™ 
and a 4-parameter logistic equation without 
constraints. 
Because significant intermolecular quenching 
effects were observed with the fluorescence-based 
substrate at concentrations >23 µM, activities 
observed at these concentrations were adjusted by 
correction factors for the purposes of kinetic 
analysis.  These factors were concentration-
dependent and derived by comparing best-fit 
equations for both free Abz and a 1:1 mixture of 
Abz and nitroY over a range of concentrations.  
Free Abz data points were best fit by a 2nd order 
polynomial function (R2 = 0.9998), whereas data 
for the Abz and nitroY mixture was best fit by a 4-
parameter logistic equation (R2=1.000).  
Correction factors were determined from ratios of 
fluorescence (i.e. RFUAbz/RFUAbz+nitroY) at specific 
concentrations, which were multiplied against the 
activities observed at those concentrations.  The 
correction factors were minor (0.98 to 1.05) 
between 0-23 µM and progressively increased 
(1.09 to 1.51) over the range of 34-172 µM.  
Similar mathematical corrections have been 
reported for other datasets where intermolecular 
quenching has been observed (Lazure, et al., 
1998). 
Yeast mating assay- Mating tests were 
performed essentially as previously described 
(Alper, et al., 2006; Kim, et al., 2005).  In brief, 
MATa yeast of the indicated genotypes were 
cultured to saturation in selective (SC-ura) liquid 
media while the MATα mating tester (IH1783; 
MATα lys1) was cultured in YEPD.  The saturated 
cultures were then diluted with fresh media to 
achieve a cell culture density of 0.95-1.05 OD600.  
The diluted MATα cell suspension (98 µL) and an 
appropriate MATa suspension (2 µL) were mixed, 
and the mixed suspension spotted (5 µL) onto 
synthetic defined (SD) solid media.  Mating was 
recorded after incubation at 30 °C for 48-72 hours.  
An equivalent portion of the mixed suspension 
was also spotted on SC-lys solid media to serve as 
a loading control for MATa cell input. 
Preparation of cell extracts and 
immunoblotting- Yeast total cellular protein 
extracts were prepared as previously described 
(Fujimura-Kamada, et al., 1997).  In brief, mid-log 
cells (2 mL of 1.0 OD600 culture) were harvested 
by centrifugation, rinsed with deionized water, 
resuspended in 1 mL of cold deionized water, and 
treated with a mixture of NaOH (0.24 N final) and 
β-mercaptoethanol (0.14 M final) for 15 min while 
on ice.  Proteins were precipitated by addition of 
TCA (11.5% final), recovered by centrifugation 
(16,000 g x 15 min), resuspended in 50 µL of 
prewarmed (~100 °C) urea sample buffer (250 
mM Tris, pH 8.0, 6 M urea, 4% SDS, and 0.01% 
bromophenol blue), and boiled for 3 min.  Samples 
were subjected to SDS-PAGE using a 10% 
polyacrylamide gel.  Immunoblot analysis was 
performed using anti-HA (Roche, Ltd., Basel, 
Switzerland) or anti-Act1p primary antibodies 
(gift of R. Meager, University of Georgia, Athens, 
GA), and appropriate HRP-conjugated secondary 
antibodies (GE Health, Inc.).  Visualization was 
achieved by chemiluminescent detection methods 
(BM Chemiluminescence Blotting Substrate, 




Ste23p is the most highly conserved M16A 
enzyme within S. cerevisiae.  Two M16A enzymes 
are encoded within the S. cerevisiae genome: 
Ste23p and Axl1p.  Primary sequence alignments 
reveal that Ste23p shares a higher degree of amino 
acid sequence identity with mammalian IDEs than 
does Axl1p (35% vs. 18% identity to HsIDE, 
respectively; Table 3).  Moreover, Ste23p shares 
roughly equal sequence conservation to 
mammalian IDEs as is shared by other fungal 
M16A enzymes, and has higher identity than 
Axl1p when compared to IDE orthologs from 
other species.  Observations from prior studies 
further indicate that Ste23p is the most 
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representative IDE ortholog in S. cerevisiae, with 
Axl1p likely having evolved to serve multiple 
functions that are specific to this organism (see 
Discussion).  Hence, Ste23p was chosen as the 
model yeast M16A enzyme for purposes of the 
current analysis.  A primary sequence alignment of 
Ste23p and RnIDE reveals notable features of the 
two enzymes, including conserved residues of the 
characteristic M16A motif (Fig. 1).  
Purification of Ste23p and RnIDE.  6xHis-
Ste23pM53-E1027 and 6xHis-RnIDEM42-L1019 were 
isolated primarily as single protein species of the 
expected molecular mass (Fig. 2).  The purified 
proteins retain N-terminal polyhistidine tags, as 
evidenced by immunoblot analysis using an anti-
6xHis antibody (Alper, Rowse, and Schmidt, 
unpublished observations).  
Ste23p and RnIDE are annotated in public 
sequence databases as polypeptides having length 
of 1027 and 1019 amino acids, respectively 
(Cherry, et al., 1998; Leinonen, et al., 2004).  
Relative to the annotated Ste23p and RnIDE 
sequences, N-terminally truncated forms of these 
enzymes were isolated for purposes of our 
analysis.  Our purification of ‘truncated’ enzymes 
− beginning, in each case, at the first in-frame 
methionine encoded downstream from the 
annotated initiator − over ‘full-length’ 
polypeptides was motivated by several factors.  
First, HsIDE was recently purified and crystallized 
as a similarly truncated protein (Shen, et al., 
2006), and to our knowledge, there has not been 
definitive assignment of the initiator methionine 
for any mammalian IDE (Baumeister, et al., 1993).  
Second, attempts to purify the full annotated 
sequence of Ste23p as a C-terminal polyhistidine 
fusion protein led to a purification product having 
T54 at its N-terminus, as determined by Edmund 
degradation analysis (Alper, Rowse, and Schmidt, 
unpublished observations); M53 was presumably 
absent due to the action of methionine 
aminopeptidase.  Third, the ‘truncated’ form of 
Ste23p most likely represents the physiologically 
relevant form of the enzyme, as supported by data 
presented elsewhere within this study (see Fig. 6).   
Ste23p proteolyzes mammalian IDE substrates 
Aβ 1-40 and insulin B chain.  Ste23p has no 
recognized physiological substrates other than the 
yeast P2 a-factor; however, the fungal enzyme is 
capable of proteolyzing the established 
mammalian IDE substrates Aβ 1-40 and insulin B 
chain (Fig. 3).  Aβ 1-40 and insulin B chain are 
common substrates of the M16A subfamily.  
These peptides have been used to study the 
proteolytic specificity of M16A enzymes even in 
instances where they are unlikely biological 
targets (Becker and Roth, 1992; Ding, et al., 1992; 
Huet, et al., 2008).  Analysis of samples from 
time-course proteolysis experiments shows the 
accumulation of multiple peaks that presumably 
correspond with Aβ 1-40 and insulin B chain 
degradation products, indicating that Ste23p 
proteolyzes each of these substrates at multiple 
sites (Figs. 3B-C).  These products are not 
observed in the presence of histidine-tagged 
glutathione S-transferase (GST-6xHis) under 
otherwise similar reaction conditions (Alper, 
Rowse, and Schmidt, unpublished observations), 
indicating that proteolysis is not attributable to a 
contaminating copurification product from the 
bacterial lysate.  Detectable accumulation of Aβ 1-
40 and insulin B chain cleavage products is 
apparent at the 1 hr and 4 hr timepoints, 
respectively, suggesting that degradation of Aβ 1-
40 occurs relatively more rapidly.  For both 
substrates, Ste23p-mediated product formation 
appears slower than that mediated by RnIDE, 
which cleaves Aβ 1-40 and insulin B chain to near 
completion within 4 hrs (Figs. 3D-E).  The identity 
of Aβ 1-40 and insulin B chain degradation 
products was not determined during this study.  
However, RnIDE is known to proteolyze both 
peptides at multiple cleavage sites, which have 
been previously evaluated (Duckworth, et al., 
1998; McDermott and Gibson, 1997; Mukherjee, 
et al., 2000). 
Comparative activity studies.  The enzymatic 
properties of Ste23p and RnIDE were compared 
using a continuous readout fluorescence assay 
under conditions of varying pH, salt concentration, 
temperature, and substrate concentration  (Fig. 4).  
Both enzymes were most active within alkaline 
environments (Figs. 4A-B), with Ste23p having a 
maximal activity of 0.49 ± 0.031 µmols x mg-1 x 
min-1 at pH 8.1, and RnIDE having maximal 
activity of 0.22 ± 0.004 µmols x mg-1 x min-1 at 
pH 9.2, the most alkaline condition evaluated.  
These values may be compared with the reported 
values for RnIDE-mediated proteolysis of a 
distinct synthetic fluorogenic Abz-GGFLRKGVQ-
EDDnp peptide, which exhibits a Vmax of ~0.2 
µmols x min-1 x mg-1, and RnIDE-mediated 
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cleavage of β–endorphin, which exhibits a Vmax of 
2.6 µmols x min-1 x mg-1, albeit under different 
assay conditions (Song, et al., 2001).  Both 
enzymes displayed enhanced enzymatic activity at 
high salt concentrations, with Ste23p and RnIDE 
activities being stimulated 2- and 6-fold, 
respectively, at the highest concentration of 
potassium chloride evaluated (Figs. 4C-D).  Both 
enzymes displayed optimal activity at or about 37 
°C (Figs. 4E-F).  Kinetic parameters for Ste23p 
and RnIDE were determined, revealing that both 
had roughly equivalent affinity for the Abz-
SEKKDNYIIKGV-nitroY-OH peptide under the 
conditions evaluated (Figs. 4G-H). Observed Km 
values were 215 ± 69 µM and 219 ± 22 µM for 
Ste23p and RnIDE, respectively.  Negligible 
activity was observed by fluorescence assay using 
a GST-6xHis control (Alper, Rowse, and Schmidt, 
unpublished observations). 
Given the otherwise similar enzymatic 
properties of Ste23p and RnIDE identified within 
our studies, we sought to determine whether the 
two enzymes exhibited comparable sensitivity to 
known modulators of M16A peptidase activity, 
including metal chelators, thiol modifiers, and 
certain inhibitors of cysteine protease activity.  
This analysis, which was conducted using the 
fluorescence assay, demonstrated that the 
sensitivities of Ste23p generally paralleled that 
observed for RnIDE (Fig. 5).  Addition of EDTA, 
TPEN, and 1,10-phenanthroline, as well as NEM, 
free cysteine, and DTT resulted in substantial 
inhibition of both Ste23p and RnIDE proteolysis 
(<40% activity).  By comparison, the non-
chelating agent 4,7-phenanthroline had limited 
impact (>60% activity), and addition of β-
mercaptoethanol had little or no effect on both 
enzymes (>80% activity).  The serine protease 
inhibitor PMSF and physiological cofactors ATP 
and GTP also had limited impact on the activity of 
both enzymes (>60% activity).  Addition of the 
competing substrate insulin to the proteolytic 
reaction mixture substantially inhibited both 
enzymes (<40% activity), but had a more 
pronounced affect on RnIDE. 
The predicted initiator methionine of Ste23p is 
dispensable for activity in vivo.  Our biochemical 
analysis revealed that the extreme N-terminus 
(residues 1-52) of the publicly annotated Ste23p 
polypeptide sequence is not essential for catalytic 
function in vitro.  To better understand the 
significance of this region in vivo, genetic and 
biochemical methods were used to assess its 
importance for expression of functional Ste23p 
(Fig. 6).  Our standard vector for Ste23p 
expression contains approximately 1.5 kb of 
genomic sequence 5´ of the STE23 ORF, inclusive 
of a distinct ORF of opposite orientation that is 
separated from STE23 by a 405 basepair intergenic 
region (Fig. 6A).  A modified version of this 
expression vector that eliminated the entire 
upstream sequence relative to the 5´ margin of the 
STE23 ORF (∆-1467 → -1) supported functional 
Ste23p expression as well as the unmodified 
plasmid (Figs. 6B-C); the reduced mating 
observed relative to WT is due to the absence of 
AXL1 in the test strain.  Loss of additional 
nucleotide sequence (∆-1467 → +156), 
specifically that encoding the annotated initiator 
codon (M1) and genomic sequence up to but not 
including the next available methionine codon 
(M53), abolished Ste23p expression and function, 
suggesting that the genetic region +1 → +156 of 
STE23 is important for gene expression. 
We next evaluated the dependence of Ste23p 
expression on M1 and M53 codons by site directed 
mutagenesis (Fig. 6D).  Mating and protein 
expression were observed with the M1A mutant, 
but not with the M53A mutant, implying that M53, 
but not M1, is necessary for expression of 
functional Ste23p. 
Ste23p is expressed in both haploid and 
diploid cell types.  Whereas expression of the 
yeast M16A homolog Axl1p is specific to haploid 
cells (Fig. 7A) (Fujita, et al., 1994), the expression 
pattern of Ste23p has not been previously reported.  
In view of the widespread occurrence of IDE 
across species and the broad tissue expression of 
M16A enzymes within multi-cellular organisms 
(Baumeister, et al., 1993), we hypothesized that 
Ste23p would be expressed in an unrestricted 
manner among the three cell types of S. cerevisiae 
– diploid, MATa and MATα haploid.  Indeed, our 
analysis indicates that Ste23p is expressed in both 
diploid and haploid cell types (Fig. 7B).  
Moreover, Ste23p expression levels appear 
relatively constant within each of the cell types 
evaluated.  Ste23p is produced at levels that are 
approximately 10-fold higher than Axl1p, as 
judged by immunoblots of serially diluted samples 
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(Alper, et al., 2006).  We interpret the unrestricted 
expression of Ste23p and its high level of 
production relative to Axl1p as potential indicators 
of an as yet undetermined function for Ste23p that 
is distinct from the enzyme’s role in P2 a-factor 
processing.  This function must be nonessential, as 
yeast deficient for STE23 and/or AXL1 are viable. 
 
DISCUSSION 
The M16A subfamily is emerging as a 
remarkable class of enzymes, most notably due to 
the proposed role of human IDE in protecting 
against Alzheimer’s disease and the unusual 
mechanism by which M16A enzymes capture and 
cleave their substrates (Selkoe, 2001; Shen, et al., 
2006). Despite their widespread species 
distribution, biological functions of M16A 
enzymes remain poorly elucidated.  Studies of 
M16A enzymes within well-characterized models 
may thus serve to distinguish functions of the 
M16A subfamily that have yet to be identified.  In 
this study, we provide evidence that such studies 
in yeast should focus on Ste23p, rather than 
Axl1p.  This conclusion is based on the higher 
degree of amino acid sequence conservation that is 
shared between Ste23p and other M16A enzymes 
and the remarkably similar biochemical properties 
of Ste23p and RnIDE. 
To our knowledge, this study presents the first 
biochemical characterization of a fungal M16A 
enzyme.  We have demonstrated that Ste23p is 
capable of proteolyzing Aβ 1-40 and insulin B 
chain (Fig. 3).  While neither substrate represents a 
likely physiological target of the fungal enzyme, 
these observations are significant in that they 
provide the first evidence that Ste23p exhibits 
conserved specificity towards these established 
substrates of mammalian M16A enzymes.  
Reciprocal substrate specificity thus emerges as a 
general property of fungal, mammalian, and 
prokaryotic M16A enzymes, as we have 
previously demonstrated that RnIDE and EcPtr can 
proteolyze a Ste23p substrate − namely, the P2 
precursor of the a-factor mating pheromone 
(Alper, et al., 2006; Kim, et al., 2005).  Our 
observation that Ste23p can proteolyze both Aβ 1-
40 and insulin B chain also indicates that substrate 
recognition by Ste23p does not require the 
presence of a farnesyl moiety, which is associated 
with P2 a-factor, the only previously recognized 
substrate of the yeast enzyme.  Collectively, these 
observations led us to develop a fluorogenic 
substrate (Abz-SEKKDNYIIKGV-nitroY-OH) 
based on the amino acid sequence of P2 a-factor, 
but lacking the farnesyl moiety of the native 
mating propheromone.  This substrate provides a 
useful tool for cross-species enzymological studies 
of the M16A subfamily. 
Using a continuous fluorescence assay to 
measure Ste23p and RnIDE-mediated proteolysis 
of the Abz-SEKKDNYIIKGV-nitroY-OH peptide, 
we have demonstrated that in addition to 
exhibiting reciprocal substrate specificity, Ste23p 
and RnIDE have similar activity profiles in 
response to alterations in pH, salt concentration, 
and temperature (Fig. 4), and various agents that 
are known modulators of M16A activity (Fig. 5).  
M16A enzymes are recognized as Zn2+ 
metallopeptidases (Becker and Roth, 1992; Ding, 
et al., 1992; Ebrahim, et al., 1991; Huet, et al., 
2008).  Consistent with expectations, Ste23p and 
RnIDE were both inhibited by certain metal 
chelating agents.  Also, like RnIDE and other 
eukaryotic M16A enzymes, but unlike bacterial 
EcPtr, Ste23p was inhibited by certain thiol 
modifiers (Affholter, et al., 1990; Becker and 
Roth, 1992; Ding, et al., 1992; Huet, et al., 2008; 
Kuo, et al., 1990).  Neither Ste23p nor RnIDE was 
sensitive to ATP or GTP addition under conditions 
of our analysis.  This observation may be 
interpreted in the context of reports that 
alternatively claim activation or inhibition of 
mammalian IDE by these cofactors (Camberos, 
2001; Huet, et al., 2008; Song, et al., 2004). 
Ste23p also exhibits a broad pH profile, having 
optimal activity over the range of pH 7.6 – 9.2.  
Like RnIDE, the yeast enzyme was found to be 
most active under alkaline conditions. We 
speculate that basic environments may enhance the 
propensity of M16A substrates to adopt a β-turn 
structure, which could enhance their interaction 
with catalytic residues in the N-terminal substrate 
binding pockets of Ste23p or RnIDE, or 
alternatively, that rate-limiting conformational 
dynamics within the M16A enzymes themselves 
are somehow altered under alkaline conditions.  
The broad pH profile exhibited by Ste23p is not 
without precedent.  Members of the M4 
metallopeptidase subfamily (e.g. thermolysin) also 
exhibit a broad pH profile and are optimally active 
at alkaline pH (pH 7.0 – 8.5; Feder and Schuck, 
2004).  We speculate that the broad range pH 
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optima exhibited by these enzymes may reflect 
their having evolved to retain maximal activity 
under a wide range of environmental conditions 
for reasons that have yet to be elucidated.  Despite 
the similar biochemical and enzymatic properties 
of RnIDE and Ste23p, whether Ste23p represents a 
true insulinase remains open to interpretation.  
While the yeast enzyme proteolyzes insulin B 
chain (Fig. 3), we were unable able to document 
cleavage of intact insulin by Ste23p, despite 
measurable inhibition of Ste23p-mediated 
proteolysis upon addition of insulin to the 
fluorogenic assay mixture (Alper, Rowse, and 
Schmidt, unpublished observations; Fig. 5). 
Available evidence collectively indicates that 
Ste23p is the most representative M16A enzyme 
within S. cerevisiae.  First, Ste23p shares higher 
primary sequence homology to mammalian IDEs 
and other M16A enzymes than does Axl1p (36% 
vs. 18% identity to HsIDE, respectively; Table 3).  
Second, like yeast-expressed RnIDE and EcPtr, 
Ste23p is incapable of supporting certain Axl1p-
dependent functions within S. cerevisiae (i.e., 
maintenance of the haploid-specific axial budding 
pattern and repression of haploid invasive growth 
(Alper, et al., 2006; Cullen and Sprague, 2002; 
Fujita, et al., 1994; Kim, et al., 2005).  Third, 
Ste23p has a relatively minor role in a-factor 
processing, despite being over-expressed 
approximately 10-fold relative to Axl1p in MATa 
haploids (Adames, et al., 1995; Alper, et al., 
2006).  We now demonstrate that Ste23p is 
expressed in diploid and MATα haploid yeast that 
are incapable of producing a-factor (Fig. 7).  This 
observation is consistent with the broad tissue 
expression of RnIDE mRNA transcripts 
(Baumeister, et al., 1993) and may ultimately 
imply a role for Ste23p in a conserved 
housekeeping function that has yet to be 
established. 
The assignment of Ste23p as the most 
representative yeast M16A ortholog supports a 
continued focus on the biological properties of this 
enzyme.  A number of bioinformatic, genetic, and 
biochemical studies have identified potential 
interactors of Ste23p that may inform its 
physiological relevance.  Yet, to our knowledge, 
none of these interactions have been thoroughly 
investigated.  Any future investigation of Ste23p 
interactors must take into account two 
observations.  First, we have previously reported 
that the STE23 stop codon was misannotated in the 
original release of the yeast genome sequence 
(Cherry, et al., 1998, Kim, 2005 #2765); a similar 
conclusion was reached through comparative 
analysis of related fungal genomes (Brachat, et al., 
2003).  The net effect of this misannotation is a 
predicted translation product with a shortened and 
altered C-terminus.  Second, we now report that 
the initiator codon of Ste23p is also misannotated 
(Fig. 6).  Previously identified genetic interactors 
of Ste23p must therefore be viewed with caution, 
as the genetic constructs used to identify these 
interactors have likely encoded forms of Ste23p 
with non-physiological N-and C-termini. 
In sum, this study provides evidence of 
extensive enzymatic similarities among Ste23p, 
RnIDE, and other M16A enzymes.  These findings 
support the conclusion that Ste23p represents a 
suitable model for studies of the M16A subfamily 
within S. cerevisiae.  We thus anticipate that 
continuing studies of Ste23p will serve to provide 
significant insight into the biological properties of 
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Table 1.  Yeast and bacterial strains used in this study 
 
a IH1783, IH1784, IH1788, and Y272 are isogenic. 
 
Strain Genotypea Reference 
IH1783 MATa trp1 leu2 ura3 his4 can1 (Michaelis and Herskowitz, 
1988) 
IH1784 MATα trp1 leu2 ura3 his4 can1 (Adames, et al., 1995) 
IH1788 MATa/α trp1 leu2 ura3 his4 can1 (Michaelis and Herskowitz, 
1988) 
IH1793 MATα lys1 (Michaelis and Herskowitz, 
1988) 
Y272 MATa trp1 leu2 ura3 his4 can1 axl1::LEU2 ste23::LEU2 (Adames, et al., 1995) 
DH5α F-f80lacZD(lacZYA-argF) U169deoR recA1 endA1 
hsdR17(rk-mk+) phoA supE44 thi-1gyr A96 relA1 ton A 
Invitrogen Inc. 
BL21(DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) Novagen Inc. 
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Table 2.  Plasmids used in this study 
 
Plasmid Genotype Reference 
p80 CEN URA3 STE23 (Adames, et al., 1995) 
pET-30b(+) pBR322 f1 KAN lacI pT7 Novagen Inc. 
pSM1569 AMP SRα-RnIDE (Bondy, et al., 1994; Seta and 
Roth, 1997) 
pRS316 CEN URA3 (Sikorski and Hieter, 1989) 
pWS371 CEN URA3 AXL1-2HAc (Kim, et al., 2005) 
pWS375 CEN URA3 STE23 (Kim, et al., 2005) 
pWS482 CEN URA3 STE23-2HAc (Kim, et al., 2005) 
pWS759 CEN URA3 STE23-2HAc (∆-1467→-1) This study 
pWS760 CEN URA3 STE23-2HAc (∆-1467→-100) This study 
pWS761 CEN URA3 STE23-2HAc (∆-1467→-200) This study 
pWS762 CEN URA3 STE23-2HAc (∆-1467→-300) This study 
pWS763 CEN URA3 STE23-2HAc (∆-1467→-400) This study 
pWS765 CEN URA3 STE23-2HAc (∆-1467→+156)  This study 
pWS769 pBR322 f1 KAN lacI pT7 6XHIS-STE23M53-E1027 This study 
pWS804 pBR322 f1 KAN lacI pT7 6XHIS-RnIDEM42-L1019 (Alper and Schmidt, 2009) 
pWS908 CEN URA3 STE23M1A-2HAc  This study 
pWS909 CEN URA3 STE23M53A-2HAc  This study 
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a Percent sequence identity calculated using multiple global sequence alignment function of Clustal W 
2.0.10. 
b Hs: Homo sapiens, Rn: Rattus norvegicus, Dm: Drosophila melanogaster, Ce: Caenorhabditis elegans, 
  Sl:Solanum lycopersicum, Um: Ustilago maydis, Sp: Schizosaccharomyces pombe, Ec: Eschericia coli. 




Figure 1.  Sequence alignment of Ste23p and RnIDE 
Ste23p and RnIDE protein sequences as annotated within the Saccharomyces Genome Database and 
Swiss-Prot Database, respectively, were aligned using Clustal W 2.0.10.  Conserved amino acids are 
shaded black, and those considered similar are shaded grey.  Closed and open arrowheads indicate the N-
terminus of recombinant Ste23p and RnIDE isolated in this study and the position of the inserted 6xHis 
affinity tag.  The characteristic HxxEH metalloprotease motif, which is conserved among all M16A 
enzymes, is indicated by a black bar.  The two amino acids within 6xHis-RnIDEM42-L1019 that are different 
from the annotated sequence are denoted in parentheses below the appropriate residue that they replace. 
 
Figure 2.  Purification recombinant Ste23p and RnIDE 
Polyhistidine tagged Ste23p and RnIDE were expressed in E. coli from pET expressions vectors (pWS769 
and pWS804, respectively) and isolated to near homogeneity.  Two-fold serial dilutions of purified 
6xHis-Ste23pM53-E1027 and 6xHis-RnIDEM42-L1019 were analyzed by SDS-PAGE and stained using 
Coomassie™ Brilliant Blue R-250.  The leftmost lane of each dilution series contains 7.5 µg of total 
protein (lanes 1 and 5).  The predicted molecular mass of 6xHis-Ste23pM53-E1027 is 113 kDa, and the 
predicted mass of 6xHis-RnIDEM42-L1019 is 114 kDa. 
 
Figure 3.  Ste23p proteolyzes Aβ 1-40 and insulin B chain 
The ability of Ste23p and RnIDE to proteolyze established IDE substrates Aβ 1-40 and insulin B chain 
was evaluated by capillary electrophoresis (CE).  Shown are chromatogram traces depicting UV 
absorbance at 200 nM.  A) Analysis of the individual components of the proteolytic reaction mixture.  
Solutions contain 24 µM Aβ 1-40, 30 µM insulin B chain, 20 nM Ste23p, or 20 nM RnIDE in Proteolysis 
Buffer, reflective of their initial concentrations within the proteolytic reaction mixture. B, C) Profile of 
Aβ 1-40 (B) and insulin B chain (C) products produced by Ste23p at indicated timepoints.  Peaks 
contributed by substrates are denoted with arrowheads, and peaks contributed by the enzymatic 
experimental component are denoted with asterisks.  D, E) Profile of Aβ 1-40 (D) and insulin B chain (E) 
produced by RnIDE after 4 hr incubation. 
 
Figure 4.  Comparative enzymatic properties of Ste23p and RnIDE 
Proteolysis of the Abz-SEKKDNYIIKGV-nitroY-OH peptide by Ste23p (A, C, E) and RnIDE (B, D, F) 
was evaluated over the indicated range of pH (A, B), salt concentration (C, D), and temperature (E, F) 
using a continuous fluorescence assay.  Proteolytic activity rates were determined from initial rates and 
are presented as a percentage of the maximal enzyme activity observed within an experiment for each 
variable evaluated.  Reported values are the average of ≥ 3 experimental replicates.  Error bars depict 
standard deviation from the mean.  Velocity vs. substrate concentration curves for Ste23p (G) and RnIDE 
(H) were determined over a substrate concentration range of 3 – 172 µM.  Km values were derived using 
the nonlinear regression function of GraphPad Prism™ 4.0. 
 
Figure 5.  Sensitivity of Ste23p and RnIDE to various agents 
Activities of Ste23p (black bars) and RnIDE (grey bars) were determined as described in Fig. 4 in the 
presence of the indicated agents relative to untreated and DMSO (dimethyl sulfoxide)-treated controls.  
Reported values are the average of three experimental replicates, and error bars indicate standard 
deviation from the mean. EDTA (ethylenediaminetetraacetic acid), TPEN (N,N,N´-tetrakis-[2-
pyridylmethyl]ethylenediamine), 1,10-P (1,10-phenanthroline), 4,7-P (4,7-phenanthroline), NEM (N-
ethylmaleimide), β-ME (β-mercaptoethanol), DTT (dithiothreitol), PMSF 
(phenylmethylsulfonylfluoride), ATP (adenosine-5´-triphosphate), and GTP (guanosine-5´-triphosphate) 
were added to a concentration of 1 mM within the proteolytic reaction mixture.  Insulin was added to an 
initial concentration of 0.8 mg/mL. 




Figure 6.  Characterization of the translation start site of Ste23p 
A) Schematic of the genomic DNA sequence that is 5´ to the predicted start codon of the STE23 open 
reading frame within pWS482.  Schematic is not drawn to scale.  B) The predicted 5´ UTR of STE23 is 
not required for expression of functional Ste23p.  A set of plasmids bearing deletions of the 5´ UTR 
contained within pWS482 (pWS759-763) and a plasmid lacking part of the STE23 ORF itself (pWS765) 
were evaluated for their ability to promote yeast mating (top panel) and Ste23p expression (middle panel).  
Yeast mating was evaluated by mixing MATα cells (IH1793) and M16A-deficient MATa cells (Y272) 
carrying the indicated plasmid, followed by selection on diploid-selective media.  Ste23p expression was 
evaluated by immunoblotting.  Equivalent percentage amounts (2%) of total cellular protein extracts were 
separated by SDS-PAGE and transferred onto blots that were probed with anti-HA and anti-Act1p 
antibodies as a loading control (middle and bottom panels, respectively).  C) Expression of Ste23p 
partially rescues the mating defect of an M16A-deficient yeast strain (Y272).  Yeast mating assays and 
analysis of Ste23p expression were performed as described in panel B; the panel order is preserved.  WT 
(IH1783) was transformed with an empty vector (pRS316), and Y272 was transformed with either 
pRS316 or a plasmid encoding Ste23p-2HA (pWS482).  D) The annotated start codon of STE23 is not 
required for expression of functional Ste23p.  Yeast mating assays and analysis of Ste23p expression 
were performed as described in panel B using plasmid transformed Y272 cells, except that 4% of each 
extract was evaluated; the panel order is preserved.  Plasmids used were pWS908-909. 
 
Figure 7.  Ste23p is expressed in both haploid and diploid yeast 
Plasmid-based expression of Ste23p (A) and Axl1p (B) was examined in MATa (IH1783), MATα 
(IH1784), and diploid (IH1788) cell types using pWS482 and pWS371, respectively.  The steady-state 
levels of the indicated HA-tagged protein (top panel) and yeast actin (bottom panel) were detected by 
immunoblotting as described in Fig. 6, except that 60% of the total cellular extract preparation was 
evaluated in the instance of Axl1p samples due to its low abundance. 
 
 
